Neoadjuvant Therapy With Tislelizumab for dMMR/MSI-H Stage II-III Colorectal Cancer

Clinical trial NCT07352280 · RECRUITING

Trial details

NCT number: NCT07352280
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Status: RECRUITING
Study type: OBSERVATIONAL

Colo-rectal Cancer (dMMR/MSI-H CRC)

Start date: 2026-02-01
Primary completion: 2027-12-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.